These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38829739)

  • 1. Blockage of L2HGDH-mediated S-2HG catabolism orchestrates macrophage polarization to elicit antitumor immunity.
    Feng S; Wang D; Jin Y; Huang S; Liang T; Sun W; Du X; Zhuo L; Shan C; Zhang W; Jing T; Zhao S; Hong R; You L; Liu G; Chen L; Ye D; Li X; Yang Y
    Cell Rep; 2024 Jun; 43(6):114300. PubMed ID: 38829739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Teleological role of L-2-hydroxyglutarate dehydrogenase in the kidney.
    Brinkley G; Nam H; Shim E; Kirkman R; Kundu A; Karki S; Heidarian Y; Tennessen JM; Liu J; Locasale JW; Guo T; Wei S; Gordetsky J; Johnson-Pais TL; Absher D; Rakheja D; Challa AK; Sudarshan S
    Dis Model Mech; 2020 Nov; 13(11):. PubMed ID: 32928875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SHISA3 Reprograms Tumor-Associated Macrophages Toward an Antitumoral Phenotype and Enhances Cancer Immunotherapy.
    Zhang S; Yu B; Sheng C; Yao C; Liu Y; Wang J; Zeng Q; Mao Y; Bei J; Zhu B; Chen S
    Adv Sci (Weinh); 2024 Sep; 11(36):e2403019. PubMed ID: 39054639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-6 signaling in macrophages is required for immunotherapy-driven regression of tumors.
    Beyranvand Nejad E; Labrie C; van Elsas MJ; Kleinovink JW; Mittrücker HW; Franken KLMC; Heink S; Korn T; Arens R; van Hall T; van der Burg SH
    J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33879600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity induces PD-1 on macrophages to suppress anti-tumour immunity.
    Bader JE; Wolf MM; Lupica-Tondo GL; Madden MZ; Reinfeld BI; Arner EN; Hathaway ES; Steiner KK; Needle GA; Hatem Z; Landis MD; Faneuff EE; Blackman A; Wolf EM; Cottam MA; Ye X; Bates ME; Smart K; Wang W; Pinheiro LV; Christofides A; Smith D; Boussiotis VA; Haake SM; Beckermann KE; Wellen KE; Reinhart-King CA; Serezani CH; Lee CH; Aubrey C; Chen H; Rathmell WK; Hasty AH; Rathmell JC
    Nature; 2024 Jun; 630(8018):968-975. PubMed ID: 38867043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The two enantiomers of 2-hydroxyglutarate differentially regulate cytotoxic T cell function.
    Foskolou IP; Cunha PP; Sánchez-López E; Minogue EA; Nicolet BP; Guislain A; Jorgensen C; Kostidis S; Zandhuis ND; Barbieri L; Bargiela D; Nathanael D; Tyrakis PA; Palazon A; Giera M; Wolkers MC; Johnson RS
    Cell Rep; 2023 Sep; 42(9):113013. PubMed ID: 37632752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blocking LTB
    Yan J; Zhu J; Li X; Yang R; Xiao W; Huang C; Zheng C
    Phytomedicine; 2023 Oct; 119():154968. PubMed ID: 37531900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary Commensal Wrestles Iron from Tumor Microenvironment to Activate Antitumoral Macrophages.
    Lee AH; Randhawa SK; Meisel M
    Cancer Res; 2024 Aug; 84(15):2400-2402. PubMed ID: 38832925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade.
    House IG; Savas P; Lai J; Chen AXY; Oliver AJ; Teo ZL; Todd KL; Henderson MA; Giuffrida L; Petley EV; Sek K; Mardiana S; Gide TN; Quek C; Scolyer RA; Long GV; Wilmott JS; Loi S; Darcy PK; Beavis PA
    Clin Cancer Res; 2020 Jan; 26(2):487-504. PubMed ID: 31636098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal L-2-hydroxyglutarate dehydrogenase activity promotes hypoxia tolerance and mitochondrial metabolism in Drosophila melanogaster.
    Mahmoudzadeh NH; Heidarian Y; Tourigny JP; Fitt AJ; Beebe K; Li H; Luhur A; Buddika K; Mungcal L; Kundu A; Policastro RA; Brinkley GJ; Zentner GE; Nemkov T; Pepin R; Chawla G; Sudarshan S; Rodan AR; D'Alessandro A; Tennessen JM
    Mol Metab; 2024 Nov; 89():102013. PubMed ID: 39182840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncometabolite d-2HG alters T cell metabolism to impair CD8
    Notarangelo G; Spinelli JB; Perez EM; Baker GJ; Kurmi K; Elia I; Stopka SA; Baquer G; Lin JR; Golby AJ; Joshi S; Baron HF; Drijvers JM; Georgiev P; Ringel AE; Zaganjor E; McBrayer SK; Sorger PK; Sharpe AH; Wucherpfennig KW; Santagata S; Agar NYR; Suvà ML; Haigis MC
    Science; 2022 Sep; 377(6614):1519-1529. PubMed ID: 36173860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CXCL9-expressing tumor-associated macrophages: new players in the fight against cancer.
    Marcovecchio PM; Thomas G; Salek-Ardakani S
    J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33637602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the vascular endothelial growth factor receptor-1 by the monoclonal antibody D16F7 to increase the activity of immune checkpoint inhibitors against cutaneous melanoma.
    Lacal PM; Atzori MG; Ruffini F; Scimeca M; Bonanno E; Cicconi R; Mattei M; Bernardini R; D'Atri S; Tentori L; Graziani G
    Pharmacol Res; 2020 Sep; 159():104957. PubMed ID: 32485280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signaling metabolite L-2-hydroxyglutarate activates the transcription factor HIF-1α in lipopolysaccharide-activated macrophages.
    Williams NC; Ryan DG; Costa ASH; Mills EL; Jedrychowski MP; Cloonan SM; Frezza C; O'Neill LA
    J Biol Chem; 2022 Feb; 298(2):101501. PubMed ID: 34929172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting TREM2 on tumor-associated macrophages enhances immunotherapy.
    Binnewies M; Pollack JL; Rudolph J; Dash S; Abushawish M; Lee T; Jahchan NS; Canaday P; Lu E; Norng M; Mankikar S; Liu VM; Du X; Chen A; Mehta R; Palmer R; Juric V; Liang L; Baker KP; Reyno L; Krummel MF; Streuli M; Sriram V
    Cell Rep; 2021 Oct; 37(3):109844. PubMed ID: 34686340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. d-2-Hydroxyglutarate is an anti-inflammatory immunometabolite that accumulates in macrophages after TLR4 activation.
    de Goede KE; Harber KJ; Gorki FS; Verberk SGS; Groh LA; Keuning ED; Struys EA; van Weeghel M; Haschemi A; de Winther MPJ; van Dierendonck XAMH; Van den Bossche J
    Biochim Biophys Acta Mol Basis Dis; 2022 Sep; 1868(9):166427. PubMed ID: 35526742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of Hierarchically Biomimetic Iron Oxide Nanosystems for Macrophage Repolarization-Promoted Immune Checkpoint Blockade of Cancer Immunotherapy.
    Kang Y; Yan J; Han X; Wang X; Wang Y; Song P; Su X; Rauf A; Jin X; Pu F; Zhang H
    ACS Appl Mater Interfaces; 2024 Jul; 16(28):36131-36141. PubMed ID: 38979627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting PHGDH reverses the immunosuppressive phenotype of tumor-associated macrophages through α-ketoglutarate and mTORC1 signaling.
    Cai Z; Li W; Hager S; Wilson JL; Afjehi-Sadat L; Heiss EH; Weichhart T; Heffeter P; Weckwerth W
    Cell Mol Immunol; 2024 May; 21(5):448-465. PubMed ID: 38409249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRD4 Inhibition by AZD5153 Promotes Antitumor Immunity via Depolarizing M2 Macrophages.
    Li X; Fu Y; Yang B; Guo E; Wu Y; Huang J; Zhang X; Xiao R; Li K; Wang B; Hu J; Sun C; Chen G
    Front Immunol; 2020; 11():89. PubMed ID: 32184777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. YTHDF2 orchestrates tumor-associated macrophage reprogramming and controls antitumor immunity through CD8
    Ma S; Sun B; Duan S; Han J; Barr T; Zhang J; Bissonnette MB; Kortylewski M; He C; Chen J; Caligiuri MA; Yu J
    Nat Immunol; 2023 Feb; 24(2):255-266. PubMed ID: 36658237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.